{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:36:21Z","timestamp":1795124181656,"version":"4.10.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","award":["312275\/2021\u20138"],"award-info":[{"award-number":["312275\/2021\u20138"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Coordination of Superior Level Staff Improvement","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Parkinson\u2019s disease (PD) is recognized as the fastest-growing neurodegenerative disorder, impacting millions of individuals worldwide. It is primarily characterized by cardinal motor symptoms, including bradykinesia (slowness of movement), tremor, rigidity, and postural instability, which significantly impair the quality of life of those affected. Traditionally, the prevailing hypothesis has attributed these motor symptoms to the degeneration and subsequent loss of dopaminergic neurons in the <jats:italic>substantia nigra pars compacta<\/jats:italic> (SNpc). Currently, emerging research suggests that this neuron-centric view may be overly simplistic and not entirely accurate. In light of this, growing attention has turned to the role of axons within the nigrostriatal pathway\u2014an extensive network connecting the <jats:italic>substantia nigra<\/jats:italic> to the striatum, essential for both dopamine transmission and the overall functioning of the motor control by the brain. By directing a focus toward this aspect, in this nano review article we examine why nigrostriatal axons deserve increased attention and should be considered a pivotal target for further therapeutic strategies in PD.<\/jats:p>","DOI":"10.1186\/s13041-025-01218-6","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T10:42:11Z","timestamp":1754044931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neurodegeneration in Parkinson\u2019s disease: are we looking at the right spot?"],"prefix":"10.1186","volume":"18","author":[{"given":"Gabriel S.","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Aurelio M.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Falcao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago F.","family":"Outeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael R.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ronaldo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"10291","key":"1218_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"key":"1218_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2018.00455","volume":"9","author":"N Gigu\u00e8re","year":"2018","unstructured":"Gigu\u00e8re N, Burke Nanni S, Trudeau L-E. On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front Neurol. 2018;9:455.","journal-title":"Front Neurol"},{"issue":"10423","key":"1218_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson\u2019s disease. Lancet. 2024;403(10423):293\u2013304.","journal-title":"Lancet"},{"key":"1218_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, Stoessl AJ, Lang AE. A biological classification of Parkinson\u2019s disease: the synneurge research diagnostic criteria. Lancet Neurol. 2024;23:191\u2013204.","journal-title":"Lancet Neurol"},{"key":"1218_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","volume":"211","author":"J Bov\u00e9","year":"2012","unstructured":"Bov\u00e9 J, Perier C. Neurotoxin-based models of Parkinson\u2019s disease. Neuroscience. 2012;211:51\u201376.","journal-title":"Neuroscience"},{"issue":"6","key":"1218_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE. Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol. 2010;67(6):715\u201325.","journal-title":"Ann Neurol"},{"issue":"9","key":"1218_CR7","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1093\/brain\/awae089","volume":"147","author":"T Pa\u00df","year":"2024","unstructured":"Pa\u00df T, Ricke KM, Hofmann P, Chowdhury RS, Nie Y, Chinnery P, et al. Preserved striatal innervation maintains motor function despite severe loss of nigral dopaminergic neurons. Brain. 2024;147(9):3189\u2013203.","journal-title":"Brain"},{"key":"1218_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s11064-021-03464-1","volume":"47","author":"AK Mishra","year":"2022","unstructured":"Mishra AK, Dixit A. Dopaminergic axons: key recitalists in Parkinson\u2019s disease. Neurochem Res. 2022;47:234\u201348.","journal-title":"Neurochem Res"},{"issue":"4","key":"1218_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, Cookson MR, Bosch LVD, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693\u2013714.","journal-title":"Cell"},{"key":"1218_CR10","doi-asserted-by":"publisher","first-page":"115040","DOI":"10.1016\/j.expneurol.2024.115040","volume":"383","author":"M Serra","year":"2025","unstructured":"Serra M, Faustini G, Brembati V, Casu MA, Pizzi M, Morelli M, et al. Early \u03b1-synuclein\/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson\u2019s disease. Exp Neurol. 2025;383:115040.","journal-title":"Exp Neurol"},{"key":"1218_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature11466","volume":"7419","author":"NX Tritsch","year":"2012","unstructured":"Tritsch NX, Ding JB, Sabatini BL. Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature. 2012;7419:262\u20136.","journal-title":"Nature"},{"issue":"3","key":"1218_CR12","doi-asserted-by":"publisher","first-page":"113834","DOI":"10.1016\/j.celrep.2024.113834","volume":"43","author":"JC Patel","year":"2024","unstructured":"Patel JC, Sherpa AD, Melani R, Witkovsky P, Wiseman MR, O\u2019Neill B, et al. GABA co-released from striatal dopamine axons dampens phasic dopamine release through autoregulatory GABAA receptors. Cell Rep. 2024;43(3):113834.","journal-title":"Cell Rep"},{"key":"1218_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41583-025-00911-8","volume":"26","author":"M Mather","year":"2025","unstructured":"Mather M. Autonomic dysfunction in neurodegenerative disease. Nat Rev Neurosci. 2025;26:276\u201392.","journal-title":"Nat Rev Neurosci"},{"key":"1218_CR14","doi-asserted-by":"crossref","unstructured":"Yuan X, Nie S, Yang Y, Liu C, Xia D, Meng L et al. 2025. Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson\u2019s disease. Nat Neurosci. 2025;28:577\u2013588.","DOI":"10.1038\/s41593-024-01866-2"},{"key":"1218_CR15","unstructured":"Cardoso F, Schmidt P. 2025. Proposed biological definitions of Parkinson\u2019s disease confuse understanding without delivering meaningful advances. J Parkinsons Dis. 2025;14:1877718X241308482."}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-025-01218-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:59:05Z","timestamp":1757329145000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-025-01218-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1186\/s13041-025-01218-6","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}